[Table_Industry] 轻工制造 [Table_ReportDate] 2025 年 04 月 24 日 菲莫国际：HNB 稳健增长，口含烟延续高增 证券研究报告 行业研究 [Table_ReportType] 行业事项点评 | [Table_StockAndRank] 轻工制造 | | | --- | --- | | 投资评级 | 看好 | | 上次评级 | 看好 | 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 [Table_Title] 菲莫国际：HNB 稳健增长，口含烟延续高增 [Table_ReportDate] 2025 年 04 月 24 日 本期内容提要: [Table_S [事件： Table_Summary 公司发布 ummary] ]2025 年一季报。2025Q1 收入为 93.01 亿美元（同比+5.8%， 经调整后同比+10.2%），其中新型烟草收入为 ...

Investment Rating - The investment rating for the company is "Positive" [2] Core Insights - The company reported a Q1 2025 revenue of $9.301 billion, representing a year-on-year increase of 5.8%, and an adjusted year-on-year increase of 10.2%. The new tobacco revenue reached $3.895 billion, with a year-on-year growth of 15.0% and an adjusted growth of 20.4%. The new tobacco segment now accounts for 41.9% of total revenue, up 3.4 percentage points year-on-year, moving closer to the company's target of two-thirds by 2030 [2][3] - The net profit for Q1 2025 was $2.690 billion, reflecting a year-on-year increase of 25.2%, driven by product mix optimization and price increases in both new tobacco and traditional cigarettes [2] - The company’s HNB (Heated Not Burned) product sales reached 37.09 billion units in Q1 2025, marking an 11.9% year-on-year increase, with a global penetration rate of 5.7%, up 0.5 percentage points year-on-year [3] - In Japan, the adjusted sales growth for IQOS reached 9.3%, with a penetration rate of 32.4%, surpassing 50% market share in 13 major cities and 8 prefectures [3] - The company’s nicotine pouch sales were 5.3 billion units in Q1 2025, showing a year-on-year increase of 27.2%, with strong performance in both the U.S. and non-U.S. markets [4] - The company anticipates a global tobacco market decline of approximately 1% in 2025, while projecting a 12%-14% increase in new tobacco product sales, with HNB sales expected to grow by 10%-12% [4] - The company aims for IQOS to capture a 10% market share in the U.S. cigarette and HNB market by 2030 [4]

Investment Rating - Industry rating is maintained as "Outperform the Market" [9] Core Insights - The report highlights the production launch of Smoore's high-end medical device project, which is expected to generate revenue of 1 billion yuan within three years [4] - The French ban on disposable e-cigarettes officially took effect on February 25, 2025, following legislative approval [5] - China's total e-cigarette export value for 2024 reached approximately 10.96 billion USD, showing a slight year-on-year decline of 1.11% [6] Summary by Sections Smoore's Medical Device Project - Smoore's skincare brand MOYAL has obtained a Class II medical device certificate and launched a non-invasive aerosol high-end medical device project, focusing on aerosol beauty equipment [4] - The project aims to achieve production in the first half of the year and expects to generate 1 billion yuan in revenue within three years [4] E-Cigarette Market Developments - The French government has implemented a ban on disposable e-cigarettes, making it the second EU country to do so after Belgium [5] - The e-cigarette export data for 2024 indicates a total export value of 10.96 billion USD, with the U.S. being the largest market, accounting for one-third of the exports [6] Company Performance - Smoore reported a revenue of 8.32 billion yuan for the first three quarters of 2024, a year-on-year increase of 4.0%, with a net profit of 1.06 billion yuan, down 11.9% [7] - The company is positioned as a global leader in aerosol technology solutions, with increasing competitive advantages amid tightening regulations [7]

Investment Rating - The report does not provide a specific investment rating for the company [1] Core Views - The company has recently achieved a Class II medical device certification for its skincare brand MOYAL, with expectations of generating a revenue of 150 million yuan in 2025 and surpassing 1 billion yuan in revenue within three years [1] - The shift towards new tobacco products is compelling leading companies to accelerate their transformation, with a projected 8.4% decline in traditional cigarette sales in the U.S. in 2024 [2] - The U.S. is expected to become a core market for heated non-combustible tobacco (HNB) products, with an estimated annual consumption of 800-900 billion pods by 2030 [3] - The company is positioned as a key supplier in the compliant market, with expectations of revenue recovery in its disposable products despite regulatory pressures [4] - Profit forecasts indicate a net profit of 1.342 billion yuan in 2024, increasing to 2.551 billion yuan by 2026, with corresponding P/E ratios of 49.8X and 30.5X respectively [5] Summary by Sections Recent Developments - The company launched a new factory for MOYAL's medical device production, aiming for significant revenue growth in the coming years [1] Market Trends - The new tobacco landscape is reshaping consumer habits, leading to a decline in traditional cigarette sales and an increased focus on HNB product development [2][3] Financial Performance - The company anticipates a recovery in revenue and profitability, with projected net profits showing a significant increase from 1.342 billion yuan in 2024 to 2.551 billion yuan in 2026 [5] Operational Insights - The company is adapting to regulatory changes and market demands, positioning itself as a core supplier in the compliant market while navigating challenges in disposable product revenues [4]